baber/WOPTO huggingface dataset:
Patent JP-3614872-B2 (JP)
IPC: C22C14/00
Filed: 1993-07-06
Granted: 2005-01-26
Abstract: There is provided a sintered titanium-based carbonitride alloy for metal cutting containing hard constituents based on Ti, Zr, Hf, V, Nb, Ta, Cr, Mo and/or W and 3-30% binder phase based on Co and/or Ni. The structure contains 10-50% by weight well-dispersed Ti-rich hard constituent grains essentially without core-rim structure with a mean grain size of 0.8-5  mu m in a conventional carbonitride alloy matrix with a mean grain size of the hard constituents of 1-2  mu m. The Ti-rich hard constituent grains are essentially rounded, non-angular grains with an approximately logarithmic normal grain size distribution with a standard deviation of <0.23 logarithmic  mu m. <IMAGE>
Patent JP-H0552453-B2 (JP)
Inventor: JEEMUZU BENJAMIN MATSUKOOMITSU
IPC: G01N1/28
Filed: 1984-09-17
Abstract: Capsules (10) in which histological tissue samples (26) are prepared for embedding and in which the samples are embedded include a first (16) and a second member (14), at least one of the members (16) including a frame that defines an opening. The members have complementary surfaces for establishing peripheral contact between the members around the opening. A porous material (20) is spread across the opening so that when the members are in peripheral contact with each other, a tissue-holding region is defined inward of the porous material. The porous material has a porosity that accesses processing liquids and liquified embedding material, such as molten paraffin, but prevents stray parts of the tissue from floating free of the region. Preferably, the second members (14) also comprise a frame defining a second opening and porous material (18) spread across the second opening. Preferably, the capsules having openings in both members are stackable in sealing relationship with one another to provide a central passageway through which processing liquids and liquified embedding material may be passed, thereby permitting simultaneous processing of a plurality of tissue samples. Preferably, one of the frames (14, 16), that has an opening covered by a porous material, is adapted to retain a protruding block of solidified embedding material (60) having the tissue sample held outward so that the one frame may be clamped in a microtome chuck (89) and tissue slices shaved from the protruding embedding material.
Patent JP-3041304-B2 (JP)
IPC: F04C18/02
Filed: 1999-07-13
Granted: 2000-05-15
Abstract: A unique method of operating a scroll compressor includes the steps of opening a capacity modulation unloader valve (40) slightly before shutdown of the scroll compressor. By opening the unloader valve, the occurrence of unpowered reverse rotation is reduced or eliminated. Most preferably, the unloader valve communicates an economizer line (34) to a suction inlet line (30). <IMAGE>
Patent JP-2591912-B2 (JP)
IPC: C08J3/03
Filed: 1994-08-23
Granted: 1997-03-19
Abstract: In the preparation of organopolysiloxane microemulsions, the components     A) organopolysiloxane,   B) emulsifier,   C) water, optionally   D) cosurfactant and optionally   E) acid are combined and mixed in any desired sequence. Microemulsions form spontaneously without the input of energy in the form of heat or strong shear forces.
Patent JP-3162232-B2 (JP)
IPC: C07D311/04
Filed: 1993-08-13
Granted: 2001-04-25
Abstract: This invention provides a novel process for the synthesis of bicyclic aromatic sulfonic acids employing reacting a bicyclic aromatic compound with sulfur trioxide-N,N-dimethylformamide complex in the presence of a water miscible, non-reactive solvent. The resulting sulfonic acid may be converted into the corresponding sulfonyl halide by the reaction with a thionyl halide. This invention further provides a novel process for the synthesis of bicyclic aromatic sulfonamides employing the reaction conditions described supra followed by an ammonolysis or amination. The resulting bicyclic aromatic sulfonamides can then be reacted with an appropriately substituted isocyanate to synthesize diaryl sulfonylureas.
Patent JP-3648688-B2 (JP)
IPC: B60W30/18
Filed: 1994-08-11
Granted: 2005-05-18
Abstract: The shift quality of an automated mechanical transmission (10) is improved and transmission wear is reduced by controlling the armature current of the motor driving the transmission shifting mechanism (22). The current is monitored by a microcontroller (16) to determine if the shifting mechanism has encountered a snag or has stalled during a shift operation. The microcontroller (16) is programmed to control the duty cycle of a pulse width modulated (PWM) voltage signal, applied to the motor, in accordance with an algorithm which provides both proportional and derivative control of the error between the measured current and a target current. The rapid reduction in current spikes through PWM control reduces the force applied to the shifting mechanism (22) and thus the sliding clutch and transmission gearing. <IMAGE>
Patent JP-2837883-B2 (JP)
IPC: A61K8/41
Filed: 1989-09-07
Granted: 1998-12-16
Abstract: The invention relates to dyeing compositions for keratinous fibres, containing: (a) at least one dye precursor belonging to the family (A) of single bases selected from paraphenylenediamines; b) at least one dye precursor of the family (B) of doubles bases selected from N,N'-diphenylalkylenediamines; the dye precursors of the families (A) and (B) being selected so that the intensity of the colouration on dyed bleached hair (VD) and the intensity on dyed and permanent-waved bleached hair VDP is such that VD-VDP = 0+/-0.5, the value being determined according to MUNSELL's notation; the mole ratio between the single bases of the family (A) and the double bases of the family (B) being between 3 and 10.
Patent JP-H0789932-B2 (JP)
IPC: C07H21/00
Filed: 1990-08-31
Abstract: In the process according to this invention, a oligonucleotide-dependent amplification procedure is performed on a first sample in which one or more of the four normal ribonucleotides or deoxyribonucleotides in the oligonucleotide is replaced with an exo-sample nucleotide. After amplification, any amplified product that may contaminate a second sample is subjected to a physical, chemical, enzymatic, or biological treatment which renders nucleic acid containing the exo-sample nucleotide substantially unamplifiable in a oligonucleotide-dependent amplification if the same oligonucleotide sequence(s) are used. The treatment may be done as a separate step or it may be done in the presence of a second sample containing nucleic acid sequences to be amplified. The amplified nucleic acid sequences derived from the first sample which contaminate the second sample are not further substantially amplified during oligonucleotide-dependent amplification of nucleic acid sequences of the second sample.
Patent JP-2702101-B2 (JP)
IPC: A61K8/00
Filed: 1995-09-19
Granted: 1998-01-21
Abstract: Direct dyeing of keratin fibres involves contacting the fibres, pre-treated with a dye compsn. contg. a direct cationic dye, with a gas contg. steam, at above 75 degrees C, for less than 2 mins. Pref. treatment is at at least 85 (esp. 85-150) degrees C, for 0.01 secs. to 2 mins. (esp. 1-10 secs.), and may be repeated. The gas may be only steam, or may contain another cpd. as gas or vapour, pref. air. The direct dye is 0.01-10 (esp. 0.05-5) wt.% of a cationic triarylmethane, naphthoquinone, anthraquinone, methine, thiazine, azoic dye, oxazine, or nitro dye or their salts.
Patent JP-3004209-B2 (JP)
IPC: A61K8/00
Filed: 1996-09-20
Granted: 2000-01-31
Abstract: Cosmetic or dermatological compsn. contains, in a cosmetically acceptable aq. medium, at least (A) a film-forming oligomer which is soluble or dispersible in the medium, having a mol. wt. determined by steric exclusion chromatography of ≤ 50000 (500-45000); and (B) a rigid, non film-forming particles having a average particle size of ≤ 1 mu m dispersed in the medium.
Patent JP-2883890-B2 (JP)
IPC: A61P31/04
Filed: 1988-10-13
Granted: 1999-04-19
Abstract: Gel-free concentrated aqueous formulations of vancomycin hydrochloride are provided which comprise the antibiotic salt at a concentration between about 12% and about 50% w/v and a gel-inhibiting compound, e.g., ethanol, at a concentration between about 1% and about 20% v/v. The gel-free formulations are especially useful in a freeze-drying process for preparing vancomycin hydrochloride as a dry flowable powder in bulk or in unit-dosage form.
Patent JP-2895605-B2 (JP)
IPC: C07D303/02
Filed: 1990-10-04
Granted: 1999-05-24
Abstract: Epoxidation of olefinic compounds by reaction with an organic hydroperoxide in the presence of a solid, heterogeneous catalyst comprising molybdenum oxide finely dispersed in silica or both molybdenum oxide and titanium oxide finely dispersed in silica.
Patent JP-2509959-B2 (JP)
IPC: C08K3/18
Filed: 1987-12-15
Granted: 1996-06-26
Abstract: Storage-stabilized compositions based on vinylidene fluoride polymers containing a metal molybdate and, as stabilizer, an effective quantity of alkali metal or alkaline-earth metal carbonate. The compositions are most particularly suitable for the manufacture of shaped objects employed in building and in aeronautics.
Patent JP-2607034-B2 (JP)
IPC: B01J20/12
Filed: 1993-12-21
Granted: 1997-05-07
Abstract: A process is described for the production of smectite-based sorbents for absorbing liquids. This process is characterised in that   (a) a smectite having a water absorption capacity of less than 115% (based on the dried smectite having a residual water content of 6% by weight) and a smectite content of about 40 to 65% by weight and/or   (b) a two-sheet silicate is mixed in the moist state with an alkali metal smectite by intensive shearing and homogenised, the mixture is gently dried and the dried mixture is comminuted.
Patent JP-2742806-B2 (JP)
IPC: A61L2/00
Filed: 1988-12-28
Granted: 1998-04-22
Abstract: A method of removing lipid soluble chemicals from a biological material containing the lipid soluble chemicals comprising bringing the biological material containing the lipid soluble chemicals into contact with an effective amount of an organic alcohol whose solubility in an aqueous solution at the temperature of use is </=0.6% and/or a halogenated hydrocarbon having more than one type of halogen, agitating the resultant mixture and achieving a phase separation of the biological material and the organic alcohol and/or halogenated hydrocarbon. The method is particularly useful for producing relatively virus free physiologically acceptable plasma.
Patent JP-2559322-B2 (JP)
IPC: A47B96/06
Filed: 1992-11-17
Granted: 1996-12-04
Abstract: System intended to ensure both the positioning and maintaining in place of an office furniture top (P) on the upper face of a support block (A), characterised in that it consists, on the one hand, of a right-angled (corner-bracket) assembly piece (1), one side of this corner bracket having the form of a horizontal sole plate (2) interlocking with the said upper face, and the other side of this corner bracket having the form of a portion of a vertical cylinder (3) whose dimensions correspond to those of a cutout made in the field of the said top and, on the other hand, of an immobilisation pin passing through two horizontal bores made so as to be located in the extension of one another, respectively in the base of the said cutout of the top and in the said cylinder portion, the head of the said pin having the shape of a corner bracket whose two wings have the shape and the dimensions of the said cutout, so as to close off the latter when the said pin joins together the said top, the said assembly piece and, consequently, the support block. <IMAGE>
Patent JP-2852033-B2 (JP)
IPC: A61L15/16
Filed: 1997-11-27
Granted: 1999-01-27
Abstract: A wound dressing having high adsorbency for bacterial toxins and the like comprises a layer of activated carbon wherein at least 10% of the pore volume of the activated carbon is represented by mesopores. The mesoporous activated carbon may be made by impregnating a cellulosic fibrous material with a liquid medium containing phosphate and an alkali metal, then carbonising and activating the impregnated fibrous material by heating in a suitable atmosphere.
Patent JP-4082522-B2 (JP)
IPC: A61K38/08
Filed: 1996-05-06
Granted: 2008-04-30
Abstract: The invention pertains to medicine, specifically to methods of obtaining biologically active substances with immunoregulatory properties, and can be used in medicine, veterinary science and experimental biochemistry. The problem addressed by the invention is that of producing a novel synthetic biologically active peptide with immunoregulatory properties of formula X-A-D-Trp-Y, in which A is D-Glu, iD-Glu; X is H or Gly, Ala, Leu, Ile, Val, NVal, Pro, Tyr, Phe, Trp, D-Ala, D-Leu, D-Ile, D-Val, D-NVal, D-Pro, D-Tyr, D-Phe, D-Trp,  gamma -aminobutyric acid,  xi -aminocaproic acid; Y is Gly, Ala, Leu, Ile, Val, NVal, Pro, Tyr, Phe, Trp, D-Ala, D-Leu, D-Ile, D-Val, D-NVal, D-Pro, D-Tyr, D-Phe, D-Trp,  gamma -aminobutyric acid, xi -aminocaproic acid, -OH or substituted amide (C1-C3). The method of producing the peptide involves the synthesis of glutamil-containing peptides in solution by scission of an internal anhydride of tributyloxycarbonyl glutamic (D or L) acid with the appropriate k-salt of D-Trp-Y. This is followed by chromatographic separation of  alpha - and  gamma -isomers. Further synthesis was carried out by building up a peptide chain using activated esters of tributyloxycarbonyl amino acids.
Patent JP-2791363-B2 (JP)
IPC: G01N15/02
Filed: 1988-12-16
Granted: 1998-08-27
Abstract: PCT No. PCT/NO88/00095 Sec. 371 Date Sep. 20, 1989 Sec. 102(e) Date Sep. 20, 1989 PCT Filed Dec. 16, 1988 PCT Pub. No. WO89/05971 PCT Pub. Date Jun. 29, 1989.The invention relates to a method and apparatus for automatic analysis for determining the size distribution of particles and their deviation from a desired shape and color. The method includes the collection of particle samples and the generation of a particle curtain in a monolayer form. It is formed by taking particles through a silo whose distance (a) to a vibrating plate positioned below has a length relative to the distance (b) between the outer edge of the plate and the center line of the silo that is large enough for the particles flowing out of the silo and down onto the plate and out over its edge to form an angle alpha  with the horizontal plane. The angle  alpha  is 50-90% of the sliding angle of the particulate material. The particle curtain is lit up and the silhouette of the particles therein is recorded and analyzed and presented in at least one place. The apparatus includes a sampler and a silo with at least one level sensor to record the level of particles in the silo and to give a signal to the sampler. The silo has a vertically displaceable extension at its outlet opening. The lower part of the extension is at a distance from a vibrating plate.
Patent JP-2794487-B2 (JP)
IPC: H02G1/12
Filed: 1990-03-05
Granted: 1998-09-03
Abstract: PCT No. PCT/EP90/00323 Sec. 371 Date Oct. 26, 1990 Sec. 102(e) Date Oct. 26, 1990 PCT Filed Mar. 5, 1990 PCT Pub. No. WO90/10329 PCT Pub. Date Sep. 7, 1990.An insulation stripping tool with a lower and an upper arm 2, 3 connected at a first pivoting point 8 with the arms ending in a handle at one end. One of the arms 2, at its other end, ends in a jaw which is rigidly joined to the handle. The stripping tool includes another jaw which is part of the other arm 3; stripping blade carriers associated with the jaws of which at least one, together with the jaw, can be shifted with respect to the other stripping blade; and an expanding spring which has two elements and is supported around the first pivoting point and moves apart the handles. The operation of the stripping tool is characterized in that the lower arm 3 carries a pulling lever 16 in a second pivoting point 17, which is shifted with respect to the first pivoting point. The pulling lever 16 is provided with a support 15 for the one element 13 of the spreading spring 14 and further has a joint 22 which is disposed in the area of the upper arm of the tool. Further, there is a stripping blade carrier which can be moved with respect to the upper jaw and the inner side of which is connected to the joint of the pulling lever. Preferably, provision is made for a gripping jaw element 23 which can be moved with respect to the lower arm 3 and has a guide hole 36 in which the guide lug with the stripping blade carrier is guided.
Patent JP-3419455-B2 (JP)
IPC: C08G65/20
Filed: 1993-09-03
Granted: 2003-06-23
Abstract: An improved process for the preparation of polytetramethylene ether glycol diesters of the formula R-CO-O(CH2-CH2-CH2-CH2-O)n-COR1, in which R and R1 are identical or different and are an alkyl radical or a derivative thereof, by polymerization of tetrahydrofuran in the presence of a fixed-bed polymerization catalyst and in the presence of a carboxylic anhydride. The use of a catalyst selected from amorphous aluminium silicate, acid-activated and calcined kaolin or zeolite instead of the known natural montmorillonite catalysts having a cryptocrystalline three-layer structure means that polymers having more uniform properties and a narrower molecular weight distribution are now accessible at a higher polymerization rate.
Patent JP-H0560949-B2 (JP)
Inventor: SUHOONEN YOOKO
IPC: A61K33/06
Filed: 1990-10-01
Abstract: For the administration of an active principle for the preventive treatment of caries in babies, a device (10) is envisaged in the form of a teat, the mouth plate (11) of which is connected releasably to the end-piece (12), the inner space (18) of which serves as a receptacle for the active principle (20) consisting, in powder or tablet form of xylite and/or combinations of xylites and fluorides, such as sodium fluoride, or xylite with sorbitol and fluorides. In the section of wall (13a) located in the lower region of the end-piece (12) are located a plurality of through-holes (15), whereas in the section of wall (13b) located in the upper region of the end-piece (12) are located a plurality of very small circular pre-cut portions (115) which can be punched through, forming through-holes (15).
Patent JP-2936182-B2 (JP)
IPC: G06F19/00
Filed: 1990-09-28
Granted: 1999-08-23
Abstract: A medication delivery device measures a preselected physical parameter of a patient as well measures at least one preselected parameter in the patient's immediate environment that relates to the physical parameter. A control element compares the preselected physical parameter measured with the preselected environmental parameter measured. A first command signal is generated when a predetermined correlation exists between the two parameters, while a second command signal is generated when it does not. The command signal can be used to base a decision to dispense medication to the patient, or to change the patient's immediate environment.
Patent JP-3438892-B2 (JP)
IPC: C07D487/04
Filed: 1994-03-03
Granted: 2003-08-18
Abstract: PCT No. PCT/EP94/00635 Sec. 371 Date Aug. 28, 1994 Sec. 102(e) Date Aug. 28, 1994 PCT Filed Mar. 3, 1994 PCT Pub. No. WO94/20501 PCT Pub. Date Sep. 15, 1994The invention relates to fungicidal compositions which comprise a carrier and, as active ingredient, a dihalotriazolopyrimidine derivative of general formula (I) in which R represents an optionally substituted branched or straight-chain alkyl or alkoxy group or an optionally substituted cycloalkyl, aryl, aryloxy, or heterocyclyl group, and Hal represents a fluroine, chlorine, bromine or iodine atom; and their use as fungicides. Certain of these dihalotriazolopyrimidine derivatives are novel and a process for the preparation of these compounds is also provided.    <IMAGE>  (I)
Patent JP-4227198-B2 (JP)
IPC: A61P9/06
Filed: 1997-10-29
Granted: 2009-02-18
Abstract: This application discloses a method of treating or preventing atrial arrhythmias which utilizes compounds which are blockers of the ultra-rapidly-activating delayed rectifier K+ current (IKur) of the human atrium in a use-dependent and/or rate dependent manner, and which provide the selective block preferentially at fast heart rates so that the effect is realized or maximized when required.
Patent JP-3761570-B2 (JP)
IPC: B01D53/22
Filed: 1995-03-22
Granted: 2006-03-29
Abstract: PCT No. PCT/DE95/00383 Sec. 371 Date Apr. 10, 1997 Sec. 102(e) Date Apr. 10, 1997 PCT Filed Mar. 22, 1995 PCT Pub. No. WO95/26314 PCT Pub. Date Oct. 5, 1995A method and apparatus is disclosed for separating a vapor-gas mixture formed above a liquid in a tank and which mixture is exhausted from the tank through an exhaust line in order to relieve overpressure in the tank. The mixture is passed from the tank through a membrane unit having a separating membrane and underpressure is generated at least intermittently, on a permeate side of the membrane unit, by a pump. This produces on the permeate side of the membrane permeate enriched with vapor and on the retentate side of the membrane retentate deleted in vapor. The permeate is returned to the tank and the retentate is exhausted to the atmosphere via the exhaust line.
Patent JP-3781773-B2 (JP)
IPC: B01D61/44
Filed: 1995-04-04
Granted: 2006-05-31
Abstract: Improved electrodialysis (ED) stacks are disclosed having one or more components selected from the group: a) cation exchange membranes having ion exchange groups predominantly sulfonic acid groups and a minor amount of weakly acidic and/or weakly basic groups or membranes which are selective to monovalent cations and simultaneously therewith, cation exchange granules selective to monovalent cations as packing in the dilute compartments; b) anion exchange membranes having as ion exchange groups only quaternary ammonium and/or quaternary phosphonium groups and substantially no primary, secondary and/or tertiary amine and/or phosphine groups or membranes which are selective to monovalent anions simultaneously therewith, anion exchange granules selective to monovalent anions as packing in the dilute compartments; c) as packing in the dilute compartment, anion exchange granules which are selective to monovalent anions, or cation exchange granules which are selective to monovalent cations, or cation exchange granules having as exchange groups a predominant amount of sulfonic acid groups and a minor amount of weakly acidic and/or weakly basic groups, or anion exchange granules consisting of organic polymers having as anion exchange groups only quaternary ammonium and/or quaternary phosphonium groups and almost no primary, secondary and/or tertiary amine and/or phosphine groups.
Patent JP-3067211-B2 (JP)
IPC: A61C19/06
Filed: 1996-03-25
Granted: 2000-07-17
Abstract: An intraoral semi-custom device for the prevention of chronic tension and common migraine headaches and temporomandibular disorders that are caused by chronic clenching of the posterior mandibular and maxillary teeth by the temporalis muscle. The semi-custom discluder is a small intraoral device which is obtained and modified by an individual wearer. The device includes a trough, curved to correspond to the curvature of the maxillary incisors, from which distally extends a dome shape. The trough is retained by a resilient material, usually silicone, which is placed into the trough by the wearer and then placed over the maxillary incisors by the wearer. The cured silicone acts as a gasket and retains the device around the wearer's upper incisors. Once in place and the wearer their mouth, the dome will come into contact with one or two lower incisor teeth prior to the posterior teeth coming into contact. This renders the temporalis muscles ineffective, preventing high pressure clenching of the posterior teeth, thus preventing tension headache, commom migraine, and temporomandibular disorders. The dome can be modified by the wearer with extension tabs in the event the posterior teeth come into contact with each other prior to the lower incisors contacting the dome.